Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Ingredion Inc director Victoria Reich received an equity grant in the form of 1,797 shares of common stock on May 20, 2026, recorded at $107.34 per share. This award consists of restricted stock units (RSUs) issued under the company’s stock incentive plan for outside directors as part of their annual retainer.
One portion of the grant covers service from April 1, 2026 to May 19, 2026, and the remaining portion represents the 2026 annual equity retainer tied to the stockholder meeting cycle. Each RSU will settle in one share of common stock and is scheduled to vest on May 19, 2027, subject to possible accelerated vesting in limited circumstances. After this grant, Reich directly holds 21,926.913 shares, including RSUs acquired through deemed dividend reinvestment.
Ingredion Inc director Charles V. Magro received an equity grant of 1,797 shares of common stock in the form of restricted stock units (RSUs) valued at $107.34 per share. This award is part of the annual retainer for outside directors under the company’s stock incentive plan.
One portion of the grant covers service from April 1, 2026 to May 19, 2026, and the remainder represents the full 2026 annual equity retainer as the company shifts director stock compensation to a twelve-month cycle aligned with the annual stockholder meeting. The RSUs, which may be settled only in shares of common stock on a one-for-one basis, will vest on May 19, 2027, subject to potential accelerated vesting in limited circumstances such as retirement, death, disability, or a Change in Control. Following this grant, Magro directly holds a total of 11,345.477 shares, including RSUs and RSUs acquired through deemed dividend reinvestment.
Ingredion Inc director Rhonda L. Jordan received a grant of 1,797 restricted stock units (RSUs) of common stock, valued at $107.34 per unit, as part of the annual equity retainer for outside directors. The award covers a short period in early 2026 plus the full 2026 annual equity retainer, reflecting a shift from calendar-year to meeting-cycle compensation. Each RSU will settle in one share of common stock and is scheduled to vest on May 19, 2027, with possible accelerated vesting upon retirement, death, disability, or a Change in Control. Following this grant, Jordan directly holds 28,908.62 shares, including RSUs acquired through deemed dividend reinvestment.
Fischer David B reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director David B. Fischer received an equity grant of 1,797 restricted stock units (RSUs) of common stock as part of his 2026 annual director retainer. The RSUs were valued at $107.34 per share on the grant date and are issued under the Ingredion Incorporated Stock Incentive Plan for outside directors.
One portion of the award covers service from April 1, 2026 to May 19, 2026, and the remaining portion represents the full 2026 annual equity retainer under a new compensation cycle aligned with the annual stockholder meeting. The RSUs may be settled only in shares of common stock on a one-for-one basis and will vest on May 19, 2027, subject to possible accelerated vesting on events such as retirement, death, disability, or a Change in Control. Following this grant, Fischer’s direct holdings, including RSUs and RSUs from deemed dividend reinvestment, total 21,434.6728 shares/units.
Ingredion Incorporated reported the voting results from its 2026 annual meeting of stockholders. Holders of common stock elected all 11 director nominees to the Board of Directors for one-year terms. Stockholders also approved, on an advisory basis, executive compensation and ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Ingredion Inc senior vice president David Eric Seip reported a compensation-related award of phantom stock. On May 15, 2026, he acquired 17.019 phantom stock units tied to the company’s common stock at a reference price of $102.62 per share, bringing his total phantom stock holdings to 13,183.2411 units.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and CIO Michael J. Leonard received a grant of 33.286 phantom stock units on May 15, 2026 under a Non-Qualified Deferred Compensation Plan. Each phantom unit represents the right to receive one share of common stock, bringing his total phantom stock holdings to 1,615.457 units.
Ingredion Incorporated has disclosed that it made a non-binding, indicative all-cash offer to acquire Tate & Lyle PLC at a price of 595 pence per Tate & Lyle share. The proposal is at an early stage and does not constitute a firm intention to make an offer.
Under the possible terms, Tate & Lyle would be allowed to pay a final dividend of up to 13 pence per share for the year ended 31 March 2026 and an interim dividend of up to 7 pence per share for the six months to 30 September 2026. Ingredion is conducting due diligence and engaging in discussions, and has until 5:00 pm (London time) on 11 June 2026 to announce a firm offer or state it does not intend to proceed, subject to any extension granted by the UK Takeover Panel.
Ingredion reported weaker results for Q1 2026, with net income attributable to the company falling to $142 million from $197 million a year earlier. Net sales slipped 1% to $1.79 billion, while gross profit declined to $401 million and gross margin narrowed from 26% to 22% due mainly to lower volumes and fixed-cost absorption.
Operating income dropped 26% to $203 million as cost of sales rose and operating expenses increased 4% to $200 million on higher employee costs. Segment performance was mixed: Texture & Healthful Solutions and Latin America grew sales modestly, but U.S./Canada net sales fell 9% and operating income there dropped sharply to $34 million, reflecting production challenges at the Argo facility and softer volumes.
Cash from operating activities decreased to $33 million from $77 million, while capital spending rose to $110 million. The company highlighted strong liquidity of $3.8 billion and total debt of $1.8 billion. Subsequent to quarter end, Ingredion approved a plan to cease operations at its Cabo, Brazil facility and disclosed an Argo “thermal event,” expecting about $43 million of related pre-tax charges and roughly $20 million of direct costs, largely in Q2 2026.
Ingredion Inc executive Robert A. Ritchie reported a routine tax-withholding share disposition related to vesting equity awards. On this Form 4, 842 shares of common stock were withheld at $110.43 per share to cover taxes when 2,880 restricted stock units and 241.005 RSUs from deemed dividend reinvestments vested. Following this event, he directly holds 31,177.7458 common shares.